Swiss National Bank decreased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 2.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 669,818 shares of the company’s stock after selling 19,000 shares during the period. Swiss National Bank owned 0.45% of Henry Schein worth $46,820,000 at the end of the most recent reporting period.
A number of other institutional investors also recently added to or reduced their stakes in the business. Cullen Frost Bankers Inc. acquired a new stake in shares of Henry Schein during the second quarter worth $36,000. CSat Investment Advisory L.P. boosted its holdings in Henry Schein by 115.6% in the first quarter. CSat Investment Advisory L.P. now owns 552 shares of the company’s stock valued at $33,000 after acquiring an additional 296 shares during the last quarter. Ibex Wealth Advisors acquired a new position in Henry Schein in the second quarter valued at $40,000. Parallel Advisors LLC boosted its holdings in Henry Schein by 67.4% in the first quarter. Parallel Advisors LLC now owns 586 shares of the company’s stock valued at $35,000 after acquiring an additional 236 shares during the last quarter. Finally, Rational Advisors LLC boosted its holdings in Henry Schein by 1,012.3% in the first quarter. Rational Advisors LLC now owns 723 shares of the company’s stock valued at $43,000 after acquiring an additional 658 shares during the last quarter.
In other Henry Schein news, Vice Chairman James P. Breslawski sold 6,856 shares of the firm’s stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $60.17, for a total value of $412,525.52. Following the transaction, the insider now directly owns 249,046 shares of the company’s stock, valued at $14,985,097.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Walter Siegel sold 4,068 shares of the firm’s stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $71.29, for a total value of $290,007.72. Following the completion of the transaction, the vice president now directly owns 48,703 shares in the company, valued at $3,472,036.87. The disclosure for this sale can be found here. Insiders sold 56,524 shares of company stock worth $3,984,949 over the last three months. 1.06% of the stock is currently owned by corporate insiders.
NASDAQ:HSIC opened at $61.58 on Tuesday. The business’s 50-day moving average is $66.65 and its two-hundred day moving average is $65.14. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.70 and a quick ratio of 0.95. Henry Schein, Inc. has a 12 month low of $56.58 and a 12 month high of $72.81. The firm has a market capitalization of $9.16 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 2.43 and a beta of 0.84.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 6th. The company reported $0.84 EPS for the quarter, beating the consensus estimate of $0.83 by $0.01. Henry Schein had a return on equity of 16.67% and a net margin of 4.18%. The company had revenue of $2.45 billion for the quarter, compared to analyst estimates of $2.48 billion. During the same period last year, the company posted $1.04 earnings per share. The firm’s revenue was up 5.7% compared to the same quarter last year. Equities analysts anticipate that Henry Schein, Inc. will post 3.46 EPS for the current year.
Henry Schein Company Profile
Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Further Reading: Street Name
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.